Geode Capital Management
OLMA icon

Geode Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Geode Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23M Buy
1,544,417
+286,976
+23% +$6.39M ﹤0.01% 1924
2025
Q4 		$31.4M Sell
1,257,441
-18,564
-1% -$330K ﹤0.01% 1759
2025
Q3 		$12.5M Sell
1,276,005
-50,118
-4% -$301K ﹤0.01% 2281
2025
Q2 		$5.65M Buy
1,326,123
+242,997
+22% +$1.08M ﹤0.01% 2667
2025
Q1 		$4.07M Buy
1,083,126
+156,964
+17% +$789K ﹤0.01% 2745
2024
Q4 		$5.4M Sell
926,162
-8,767
-0.9% -$87.6K ﹤0.01% 2710
2024
Q3 		$11.2M Sell
934,929
-125,170
-12% -$1.6M ﹤0.01% 2314
2024
Q2 		$11.5M Buy
1,060,099
+220,754
+26% +$2.39M ﹤0.01% 2239
2024
Q1 		$9.5M Buy
839,345
+14,512
+2% +$187K ﹤0.01% 2353
2023
Q4 		$11.6M Buy
824,833
+169,079
+26% +$2.27M ﹤0.01% 2251
2023
Q3 		$8.1M Buy
655,754
+48,414
+8% +$493K ﹤0.01% 2386
2023
Q2 		$5.48M Buy
607,340
+257,394
+74% +$1.55M ﹤0.01% 2629
2023
Q1 		$1.21M Buy
349,946
+13,047
+4% +$53.2K ﹤0.01% 3256
2022
Q4 		$825K Buy
336,899
+9,364
+3% +$27.3K ﹤0.01% 3446
2022
Q3 		$903K Buy
327,535
+40,288
+14% +$171K ﹤0.01% 3439
2022
Q2 		$1.17M Sell
287,247
-187,651
-40% -$595K ﹤0.01% 3353
2022
Q1 		$2.02M Buy
474,898
+14,537
+3% +$80.1K ﹤0.01% 3248
2021
Q4 		$4.31M Sell
460,361
-4,926
-1% -$102K ﹤0.01% 2978
2021
Q3 		$12.8M Buy
465,287
+252,765
+119% +$6.82M ﹤0.01% 2281
2021
Q2 		$5.95M Sell
212,522
-1,701
-0.8% -$48.4K ﹤0.01% 2799
2021
Q1 		$7.11M Buy
214,223
+187,725
+708% +$8.04M ﹤0.01% 2598
2020
Q4 		$1.27M Buy
+26,498
New +$1.24M ﹤0.01% 3284

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Geode Capital Management's OLMA Position: Q1 2026 in Review

Geode Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 23% in Q1 2026, buying an estimated $6.39M and bringing the position to 1,544,417 shares worth $23M. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Geode Capital Management first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $31.4M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Geode Capital Management held 1,544,417 shares of Olema Pharmaceuticals worth $23M as of Q1 2026.
  • Geode Capital Management bought 286,976 Olema Pharmaceuticals shares in Q1 2026, an estimated $6.39M.
  • Olema Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1924 holding.
  • Geode Capital Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Geode Capital Management's Olema Pharmaceuticals position peaked at $31.4M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.